These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody. Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ; Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432 [TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age. Blatter MM; Klein NP; Shepard JS; Leonardi M; Shapiro S; Schear M; Mufson MA; Martin JM; Varman M; Grogg S; London A; Cambron P; Douha M; Nicholson O; da Costa C; Innis BL Pediatr Infect Dis J; 2012 Aug; 31(8):e133-40. PubMed ID: 22622699 [TBL] [Abstract][Full Text] [Related]
31. The pathogenesis of neonatal autoimmune and autoinflammatory diseases: a comprehensive review. Chang C J Autoimmun; 2013 Mar; 41():100-10. PubMed ID: 23375846 [TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190 [TBL] [Abstract][Full Text] [Related]
33. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age. Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100 [TBL] [Abstract][Full Text] [Related]
34. A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process. Marshall GS; Senders SD; Shepard J; Twiggs JD; Gardner J; Hille D; Hartzel J; Valenzuela R; Stek JE; Helmond FA Hum Vaccin Immunother; 2016 Aug; 12(8):2188-2196. PubMed ID: 27149048 [TBL] [Abstract][Full Text] [Related]
35. Extinction of the human leukocyte antigen homozygosity effect after two doses of the measles-mumps-rubella vaccine. St Sauver JL; Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA Hum Immunol; 2005 Jul; 66(7):788-98. PubMed ID: 16112026 [TBL] [Abstract][Full Text] [Related]